Home › Funds › STEMPOINT CAPITAL LP › MNPR
STEMPOINT CAPITAL LP position in MNPR
MONOPAR THERAPEUTICS INC · Health Care
STEMPOINT CAPITAL LP reported holding 30,125 shares of MNPR (MONOPAR THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 0.62% of its reported portfolio and ranking #49 among its reported holdings. STEMPOINT CAPITAL LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How STEMPOINT CAPITAL LP's MNPR position evolved
STEMPOINT CAPITAL LP first disclosed a stake in MNPR in Q2 2026 at 30,125 shares (US$2.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 30.12K | $2.79M | New |
About MNPR and 13F data
MNPR (MONOPAR THERAPEUTICS INC) is a Health Care company. 84 other funds we track also report a position in MNPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$61.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$30.0M), Saturn V Capital Management LP (US$28.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MNPR
- RA CAPITAL MANAGEMENT, L.P. 667.21K sh · $61.78M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 323.75K sh · $29.98M · Q2 2026
- Saturn V Capital Management LP 311.98K sh · $28.89M · Q2 2026
- Siren, L.L.C. 270.12K sh · $25.01M · Q2 2026
- ADAR1 Capital Management, LLC 217.59K sh · $20.15M · Q2 2026
- TCG Crossover Management, LLC 203.33K sh · $18.83M · Q2 2026
- Vivo Capital, LLC 90.50K sh · $8.38M · Q2 2026
- Ikarian Capital, LLC 47.86K sh · $4.43M · Q2 2026
- Ishara Investments LP 12.30K sh · $1.14M · Q2 2026
- Martin Investment Management, LLC 2.33K sh · $215.46K · Q2 2026
More on STEMPOINT CAPITAL LP
FAQ
How long has STEMPOINT CAPITAL LP held MNPR?
STEMPOINT CAPITAL LP has disclosed MNPR holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is STEMPOINT CAPITAL LP's current position in MNPR?
As of Q2 2026, STEMPOINT CAPITAL LP holds 30.12K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $2.79M, representing 0.62% of its reported portfolio and ranking #49.
Has STEMPOINT CAPITAL LP been buying or selling MNPR?
In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP newly opened its position in MNPR.
Which other funds hold MNPR?
Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., Saturn V Capital Management LP, among 84 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.